LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio joins the European APPROVALS project

25/09/2024
PRESS RELEASE

Brussels, 25 September 2024

EuropaBio, the leading voice for the European biotechnology industry, joined the European APPROVALS project (Accelerating PROteins innoVAtors beyond regulatory Sandoboxes) launched on September 25th, 2024, and supported by the European Union’s Horizon Europe Program.

APROVALS is composed of eight partners, including Genopole, Campania Bioscience, EuropaBio, Irish Bioeconomy Foundation, Planet B.io, Smile Incubator Ab, Pôle Vitagora, VTT.

The project runs for 2.5 years and aims to aims to facilitate the deployment of emerging technologies in cellular agriculture, provide a supportive environment for testing and developing new solutions and enhance collaboration among innovators, regulators, and stakeholders.

A European Partnership to Advance Cellular Agriculture

In the coming decades, society will face the challenge of feeding a growing global population expected to reach 10 billion people by 2050. The latest advancements in biotechnology could offer solutions in food production. Cellular agriculture is a process that gives rise to a new range of foods, which can be derived from whole edible microbial cells (including bacteria, fungi, yeast, and algae), specific functional ingredients produced by precision fermentation, or even animal cells cultivated in the lab.

EuropaBio joins the European APPROVALS project


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.